Research network involvement and addiction treatment center staff: Counselor attitudes toward buprenorphine

被引:39
作者
Knudsen, Hannah K.
Ducharme, Lori J.
Roman, Paul M.
机构
[1] Univ Georgia, Inst Behav Res, Athens, GA 30602 USA
[2] Univ Georgia, Dept Sociol, Athens, GA 30602 USA
关键词
SUBSTANCE-ABUSE; METHADONE; TRIAL; DETOXIFICATION; CHALLENGES; INCENTIVES; MANAGEMENT; NALTREXONE; INNOVATION; ADOPTION;
D O I
10.1080/10550490701525418
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The National Institute on Drug Abuse's Clinical Trials Network ( CTN) aims to improve addiction treatment in the United States in part through technology transfer. Given the importance of clinicians in the technology transfer process, this research compares 561 CTN- affiliated and 1,745 non- CTN counselors' ratings of buprenorphine acceptability. CTN- affiliated counselors reported significantly greater acceptability than non- CTN counselors. This difference was not explained by controlling for counselor characteristics, but was completely attenuated by measures of buprenorphine- specific training and buprenorphine implementation. These data suggest that the CTN's impact on counselor attitudes may be attributed to the greater exposure to buprenorphine received by CTN- affiliated counselors.
引用
收藏
页码:365 / 371
页数:7
相关论文
共 37 条
[1]   Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience [J].
Amass, L ;
Ling, W ;
Freese, TE ;
Reiber, C ;
Annon, JJ ;
Cohen, AJ ;
McCarty, D ;
Reid, MS ;
Brown, LS ;
Clark, C ;
Ziedonis, DM ;
Krejci, J ;
Stine, S ;
Winhusen, T ;
Brigham, G ;
Babcock, D ;
Muir, JA ;
Buchan, BJ ;
Horton, T .
AMERICAN JOURNAL ON ADDICTIONS, 2004, 13 :S42-S66
[2]  
[Anonymous], 2004, Treatment Improvement Protocol 40
[3]   Clinicians' beliefs and awareness of substance abuse treatments in research-and nonresearch-affiliated programs [J].
Arfken, CL ;
Agius, E ;
Dickson, MW ;
Anderson, HL ;
Hegedus, AM .
JOURNAL OF DRUG ISSUES, 2005, 35 (03) :547-558
[4]   Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study [J].
Carroll, KM ;
Ball, SA ;
Nich, C ;
Martino, S ;
Frankforter, TL ;
Farentinos, C ;
Kunkel, LE ;
Mikulich-Gilbertson, SK ;
Morgenstern, J ;
Obert, JL ;
Polcin, D ;
Snead, N ;
Woody, GE .
DRUG AND ALCOHOL DEPENDENCE, 2006, 81 (03) :301-312
[5]  
DAMANPOUR F, 1991, ACAD MANAGE J, V34, P555, DOI 10.5465/256406
[6]   Staff beliefs about addiction treatment [J].
Forman, RF ;
Bovasso, G ;
Woody, G .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2001, 21 (01) :1-9
[7]   Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone [J].
Fudala, PJ ;
Bridge, TP ;
Herbert, S ;
Williford, WO ;
Chiang, CN ;
Jones, K ;
Collins, J ;
Raisch, D ;
Casadonte, P ;
Goldsmith, RJ ;
Ling, W ;
Malkerneker, U ;
McNicholas, L ;
Renner, J ;
Stine, S ;
Tusel, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :949-958
[8]   Introduction - I Putting drug abuse research to use in real-life settings [J].
Hanson, GR ;
Leshner, AI ;
Tai, B .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2002, 23 (02) :69-70
[9]  
*I MED, 2003, UNEQ TREATM CONF RAC
[10]  
Institute of Medicine, 1998, BRIDG GAP PRACT RES